NuCana Sponsored ADR - 48 Year Dividend History | NCNA

Historical dividend payout and yield for NuCana Sponsored ADR (NCNA) since 1971. The current TTM dividend payout for NuCana Sponsored ADR (NCNA) as of June 18, 2019 is $0.00. The current dividend yield for NuCana Sponsored ADR as of June 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.378B $0.000B
NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company's pipeline of products includes Acelarin, NUC-3373 and NUC-7738 which are in clinical stage. NuCana PLC is based in EDINBURGH, United Kingdom.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $85.546B 10.39
Bio-Techne Corp (TECH) United States $7.848B 53.55